Altimmune, Inc. (ALT) Tops Q2 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Starlink, AI Capex, rockets: deep dive into SpaceX’s first ever public report
• Benchmark Reiterates Buy Rating on Sony Corp. (6785:JP) (SONY)
• Holley expands retail distribution with unnamed national partner